z-logo
Premium
Two‐year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy
Author(s) -
Maghrabi Adam H.,
Wolski Kathy,
Abood Beth,
Licata Angelo,
Pothier Claire,
Bhatt Deepak L.,
Nissen Steven,
Brethauer Stacy A.,
Kirwan John P.,
Schauer Philip R.,
Kashyap Sangeeta R.
Publication year - 2015
Publication title -
obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.438
H-Index - 199
eISSN - 1930-739X
pISSN - 1930-7381
DOI - 10.1002/oby.21150
Subject(s) - medicine , bone mineral , vitamin d and neurology , weight loss , lean body mass , surgery , sleeve gastrectomy , bone density , diabetes mellitus , randomized controlled trial , osteoporosis , urology , obesity , endocrinology , body weight , gastric bypass
Objective To determine the 2‐year outcomes of Roux‐en‐Y gastric bypass (RYGB) and sleeve gastrectomy (SG) vs. intensive medical therapy (IMT) on lean body mass, total bone mass, and bone mineral density (BMD) measures from the STAMPEDE trial. Methods 54 subjects (BMI: 36 ± 1 kg/m 2 , age: 48 ± 4 years) with type 2 diabetes (T2DM) (HbA 1c : 9.7 ± 2%) were randomized to IMT, RYGB, or SG and underwent DXA at baseline and at 1 and 2 years. Results At 2 years, the reduction in BMI was similar after RYGB and SG and was greater than IMT ( P  < 0.001). Lean mass was reduced by ∼10%, total bone mineral content reduced by ∼8%, and hip BMD reduced by ∼9% in both surgical groups and was significantly greater than IMT despite increases in vitamin D intake in all groups. The change in hip BMD correlated with weight loss ( r  = 0.84, P  < 0.0001) and changes in lean mass ( r  = 0.74, P  < 0.0001) and leptin ( r  = 0.53, P  < 0.0001). Peripheral fractures were self‐reported in RYGB (4/18 patients), SG (2/19 patients), and IMT (4/16 patients). Conclusions Surgically induced weight loss is associated with modest reductions in lean mass, bone mineral content, and BMD, despite calcium and vitamin D supplementation in patients with T2DM. Awareness for bone loss is indicated for patients undergoing bariatric procedures.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here